Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Maria Croce

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancerMaria Cristina Picchio, Eric Santos Martin, Rossano Cesari, et al.
Cancer Research|July 9, 2009
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cellsFrancesca Fornari, Laura Gramantieri, Catia Giovannini, et al.
Molecular Carcinogenesis|December 25, 2018
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146aValeria Bertagnolo, Silvia Grassilli, Stefano Volinia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2002
TCL1 participates in early embryonic development and is overexpressed in human seminomasMaria Grazia Narducci, Maria Teresa Fiorenza, Sang-Moo Kang, et al.
Nucleic Acids Research|October 24, 2008
UCbase & miRfunc: a database of ultraconserved sequences and microRNA functionCristian Taccioli, Enrica Fabbri, Rosa Visone, et al.
Oncotarget|January 21, 2017
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53Giorgio Malpeli, Stefano Barbi, Simonetta Zupo, et al.
Oncotarget|July 25, 2018
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathwaysGiorgio Malpeli, Stefano Barbi, Gabriele Tosadori, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Hematological Oncology|January 6, 2021
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcomaMaria Rosaria Sapienza, Fabio Fuligni, Federica Melle, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancerMaria Cristina Picchio, Eric Santos Martin, Rossano Cesari, et al.
Cancer Research|July 9, 2009
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cellsFrancesca Fornari, Laura Gramantieri, Catia Giovannini, et al.
Molecular Carcinogenesis|December 25, 2018
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146aValeria Bertagnolo, Silvia Grassilli, Stefano Volinia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2002
TCL1 participates in early embryonic development and is overexpressed in human seminomasMaria Grazia Narducci, Maria Teresa Fiorenza, Sang-Moo Kang, et al.
Nucleic Acids Research|October 24, 2008
UCbase & miRfunc: a database of ultraconserved sequences and microRNA functionCristian Taccioli, Enrica Fabbri, Rosa Visone, et al.
Oncotarget|January 21, 2017
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53Giorgio Malpeli, Stefano Barbi, Simonetta Zupo, et al.
Oncotarget|July 25, 2018
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathwaysGiorgio Malpeli, Stefano Barbi, Gabriele Tosadori, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Hematological Oncology|January 6, 2021
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcomaMaria Rosaria Sapienza, Fabio Fuligni, Federica Melle, et al.
Pageof 6